Actinic keratosis
Drug research and approvals for actinic keratosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 36 studies of actinic keratosis are recruiting on ClinicalTrials.gov, Health Canada has authorized 6 drug trials for it since 2013, and the EU has 3 authorised medicines for it.
- Recruiting worldwide: 36
- Trials authorized in Canada: 6
- FDA orphan approvals: 0
- EU medicines: 3
Recruiting Now
Newest start dates first, of 36 recruiting on ClinicalTrials.gov ↗- Using an Artificial Intelligence (AI) Tool for Melanoma DiagnosisNCT07890415 · Phase 3 · Memorial Sloan Kettering Cancer Center · starts Oct 15, 2026
- Basal Cell Carcinoma Chemoprevention TrialNCT05212246 · Phase 3 · VA Office of Research and Development · starts Oct 6, 2026
- Multimodal Laser Treatment of Photodamaged SkinNCT07789002 · Not applicable · Merete Haedersdal · starts Sep 1, 2026
- An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the FaceNCT07729579 · Phase 1 · Sun Pharmaceutical Industries Limited · starts Aug 4, 2026
- Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton…NCT07280091 · Not reported · Assistance Publique - Hôpitaux de Paris · starts May 26, 2026
- A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant RecipientsNCT07286318 · Early Phase 1 · Marissa Lobl · starts May 1, 2026
- Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)NCT07657988 · Not reported · Avant Health LLC · starts Apr 2, 2026
- Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT07538583 · Phase 2 / Phase 3 · Quoin Pharmaceuticals · starts Mar 19, 2026
- Actinic Keratoses Treated With 5-fluorouracil Plus AluminumNCT07401277 · Phase 1 · West Virginia University · starts Feb 6, 2026
- A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.NCT07318675 · Phase 1 · Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · starts Dec 25, 2025
Trials Authorized in Canada
Newest first; search them all in Canada trials| Dec 15, 2015 | Efficacy and safety of leo 43204 in field treatment of actinic keratosis on face or chest including 12-month follow-up.INGENOL DISOXATE (LEO 43204) | LEO Pharma | Closed |
| Dec 14, 2015 | Efficacy and safety of leo 43204 in field treatment of actinic keratosis on balding scalp including 12-month follow-up.INGENOL DISOXATE (LEO 43204) | LEO Pharma | Closed |
| Apr 9, 2015 | Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp or approximately 250 cm2 on the chestPICATO (LP0105, INGENOL MEBUTATE) | LEO Pharma | Ongoing |
| Dec 17, 2014 | Ingenol mebutate (picato®) with methyl aminolevulinate photodynamic therapy for the treatment of actinic keratosis.INGENOL MEBUTATE | DR. JASON RIVERS | Closed |
| Oct 17, 2014 | Safety and efficacy of escalating doses of leo 43204 applied once daily for two consecutive days on approximately 250 cm2 on trunk and extremities in subjects…LEO 43204 | LEO Pharma | Ongoing |
| May 22, 2014 | Leo safety and efficacy of escalating doses of two leo 43204 formulations applied once daily for two consecutive days on full face or approximately 250 cm2 (40…LEO 43204 | LEO Pharma | Ongoing |
Medicines Authorised in the EU
Newest first| Jul 16, 2021 | Klisyritirbanibulin | Almirall, S.A. | EMA ↗ |
| Aug 23, 2012 | Zyclaraimiquimod | Viatris Healthcare Limited | EMA ↗ |
| Dec 13, 2011 | Ameluz5-aminolevulinic acid hydrochloride | Biofrontera Bioscience GmbH | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA